- Home
- RGEN vs AD Comparison
RGEN vs AD Comparison
Compare RGEN & AD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- AD
- Stock Information
- Founded
- RGEN 1981
- AD 1983
- Country
- RGEN United States
- AD United States
- Employees
- RGEN N/A
- AD N/A
- Industry
- RGEN Medical/Dental Instruments
- AD Telecommunications Equipment
- Sector
- RGEN Health Care
- AD Telecommunications
- Exchange
- RGEN Nasdaq
- AD Nasdaq
- Market Cap
- RGEN 6.5B
- AD 6.4B
- IPO Year
- RGEN N/A
- AD N/A
- Fundamental
- Price
- RGEN $119.75
- AD $50.00
- Analyst Decision
- RGEN Buy
- AD
- Analyst Count
- RGEN 10
- AD 0
- Target Price
- RGEN $163.78
- AD N/A
- AVG Volume (30 Days)
- RGEN 706.1K
- AD 283.0K
- Earning Date
- RGEN 11-11-2025
- AD 10-31-2025
- Dividend Yield
- RGEN N/A
- AD 45.96%
- EPS Growth
- RGEN N/A
- AD N/A
- EPS
- RGEN N/A
- AD N/A
- Revenue
- RGEN $673,956,000.00
- AD $3,700,000,000.00
- Revenue This Year
- RGEN $16.74
- AD $0.37
- Revenue Next Year
- RGEN $13.86
- AD N/A
- P/E Ratio
- RGEN N/A
- AD N/A
- Revenue Growth
- RGEN 8.73
- AD N/A
- 52 Week Low
- RGEN $102.97
- AD $49.46
- 52 Week High
- RGEN $182.52
- AD $79.17
- Technical
- Relative Strength Index (RSI)
- RGEN 50.04
- AD N/A
- Support Level
- RGEN $112.73
- AD N/A
- Resistance Level
- RGEN $122.71
- AD N/A
- Average True Range (ATR)
- RGEN 4.63
- AD 0.00
- MACD
- RGEN -0.46
- AD 0.00
- Stochastic Oscillator
- RGEN 55.87
- AD 0.00
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.